NO149962C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater

Info

Publication number: NO149962C
Authority: NO; Norway
Prior art keywords: preparation; therapeutic active; analogy procedure; imidazold; derivatives
Prior art date: 1977-09-19

Application number

NO783155A

Other languages

English (en)

Norwegian (no)

Other versions

NO149962B (no

NO783155L (no

Inventor

Anna Krasso

Ernst-Peter Krebs

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1977-09-19

Filing date

1978-09-18

Publication date

1984-07-25

1978-09-18 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

1979-03-20 Publication of NO783155L publication Critical patent/NO783155L/no

1984-04-16 Publication of NO149962B publication Critical patent/NO149962B/no

1984-07-25 Publication of NO149962C publication Critical patent/NO149962C/no

Links

230000001225 therapeutic effect Effects 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/26—Radicals substituted by halogen atoms or nitro radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

NO783155A 1977-09-19 1978-09-18 Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater NO149962C (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
LU78140		1977-09-19
CH814978		1978-07-28

Publications (3)

Publication Number	Publication Date
NO783155L NO783155L (no)	1979-03-20
NO149962B NO149962B (no)	1984-04-16
NO149962C true NO149962C (no)	1984-07-25

Family

ID=25702876

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO783155A NO149962C (no)	1977-09-19	1978-09-18	Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater

Country Status (36)

Country	Link
US (2)	US4182766A (fr)
EP (1)	EP0001279B1 (fr)
JP (1)	JPS5459274A (fr)
AR (1)	AR224350A1 (fr)
AT (1)	AT368152B (fr)
AU (1)	AU519711B2 (fr)
BG (1)	BG28708A3 (fr)
BR (1)	BR7806148A (fr)
CA (1)	CA1106849A (fr)
DD (1)	DD138210A5 (fr)
DE (2)	DE2840591A1 (fr)
DK (1)	DK406578A (fr)
EG (1)	EG13530A (fr)
ES (1)	ES473451A1 (fr)
FI (1)	FI64365C (fr)
FR (1)	FR2403340A1 (fr)
GB (1)	GB2004281B (fr)
GR (1)	GR73069B (fr)
HU (1)	HU176111B (fr)
IE (1)	IE47363B1 (fr)
IL (1)	IL55557A (fr)
IN (1)	IN148930B (fr)
IT (1)	IT1098858B (fr)
MC (1)	MC1213A1 (fr)
MT (1)	MTP835B (fr)
NL (1)	NL7809529A (fr)
NO (1)	NO149962C (fr)
NZ (1)	NZ188405A (fr)
OA (1)	OA06054A (fr)
PH (1)	PH16342A (fr)
PL (1)	PL114494B1 (fr)
PT (1)	PT68573A (fr)
RO (1)	RO75258A (fr)
SE (1)	SE7809792L (fr)
SU (1)	SU793390A3 (fr)
YU (1)	YU216778A (fr)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE7804231L (sv) *	1978-04-14	1979-10-15	Haessle Ab	Magsyrasekretionsmedel
US4321372A (en) *	1980-06-16	1982-03-23	Pfizer Inc.	Antiulcer thiazol-2-ylcarbamoyl-carboxylic acids, esters and amides
US4359465A (en) *	1980-07-28	1982-11-16	The Upjohn Company	Methods for treating gastrointestinal inflammation
CH644116A5 (de) *	1980-08-21	1984-07-13	Hoffmann La Roche	Imidazolderivate.
US4368201A (en) *	1981-07-20	1983-01-11	Usv Pharmaceutical Corporation	Tetrahydronaphthoxazoles
IL66340A (en) *	1981-08-13	1986-08-31	Haessle Ab	Pharmaceutical compositions comprising pyridylmethyl-thiobenzimidazole derivatives,certain such novel derivatives and their preparation
HU193408B (en) *	1983-05-03	1987-10-28	Byk Gulden Lomberg Chem Fqb	Process for production of new tree-cycle compounds
ZW4585A1 (en) *	1984-04-19	1985-11-20	Hoffmann La Roche	Imidazole derivatives
GB2161160B (en) *	1984-07-06	1989-05-24	Fisons Plc	Heterocyclic sulphinyl compounds
EP0174717B1 (fr) *	1984-07-06	1992-01-22	FISONS plc	Benzimidazoles, et leur préparation, formulation et application comme inhibiteur de sécrétion d'acide gastrique
SE8404065D0 (sv) *	1984-08-10	1984-08-10	Haessle Ab	Novel biologically active compounds
DE3501497A1 (de) *	1985-01-18	1986-07-24	Boehringer Mannheim Gmbh, 6800 Mannheim	Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte
AU5768886A (en)	1985-05-24	1986-11-27	G.D. Searle & Co.	2-((1-h-benzimidazol-2-ylsulfinyl)methyl)benzenamines
US5869513A (en) *	1985-05-24	1999-02-09	G. D. Searle & Co.	2- (1H-benzimidazol-2-ylsulfinyl)methyl!benzenamines
DK337086A (da) *	1985-08-12	1987-02-13	Hoffmann La Roche	Benzimidazolderivater
SE8505112D0 (sv) *	1985-10-29	1985-10-29	Haessle Ab	Novel pharmacological compounds
SE8600658D0 (sv) *	1986-02-14	1986-02-14	Haessle Ab	Novel composition of matter
US4772619A (en) *	1986-07-17	1988-09-20	G. D. Searle & Co.	[(1H-benzimidazol-2-ylsulfinyl)methyl]-2-pyridinamines
US4687775A (en) *	1986-07-17	1987-08-18	G. D. Searle & Co.	2-[(Imidazo[1,2-a]pyridinylmethyl)sulfinyl]-1H-benzimidazoles
US4721718A (en) *	1986-08-18	1988-01-26	G. D. Searle & Co.	2-[(imidazo[1,2-a]pyridin-3-ylmethyl)sulfinyl]-1H-benzimidazoles useful in the treatment and prevention of ulcers
SE8604566D0 (sv) *	1986-10-27	1986-10-27	Haessle Ab	Novel compunds
SE8604998D0 (sv)	1986-11-21	1986-11-21	Haessle Ab	Novel pharmacological compounds
NZ234564A (en)	1986-11-21	1991-04-26	Haessle Ab	1-substituted benzimidazoles and pharmaceutical compositions
FI91754C (fi) *	1986-12-02	1994-08-10	Tanabe Seiyaku Co	Analogiamenetelmä lääkeaineena käyttökelpoisen imidatsolijohdannaisen valmistamiseksi
DE3701277A1 (de) *	1987-01-17	1988-07-28	Boehringer Mannheim Gmbh	Neue tricyclische benzimidazole, verfahren zu ihrer herstellung und verwendung als arzneimittel
US4931557A (en) *	1988-10-17	1990-06-05	Eli Lilly And Company	Method of resolving cis 3-amino-4-(2-furyl)vinyl)-1-methoxycarbonylmethyl-azetidin-2-one and di-p-toluoyl-tartaric acid salts thereof
SE8804629D0 (sv) *	1988-12-22	1988-12-22	Ab Haessle	New therapeutically active compounds
SE8804628D0 (sv)	1988-12-22	1988-12-22	Ab Haessle	New compounds
IE64199B1 (en) *	1988-12-22	1995-07-12	Haessle Ab	Compound with gastric acid inhibitory effect and process for its preparation
US5049674A (en) *	1989-12-20	1991-09-17	Aktiebolaget Hassle	Therapeutically active fluoro substituted benzimidazoles
US5274099A (en) *	1989-12-20	1993-12-28	Aktiebolaget Hassle	Therapeutically active fluoro substituted benzimidazoles
US4965269A (en) *	1989-12-20	1990-10-23	Ab Hassle	Therapeutically active chloro substituted benzimidazoles
SE9002043D0 (sv) *	1990-06-07	1990-06-07	Astra Ab	Improved method for synthesis
SE9002206D0 (sv)	1990-06-20	1990-06-20	Haessle Ab	New compounds
BR9306702A (pt) *	1992-07-08	1998-12-08	Monsanto Co	Benzimidazóis para aliviar úlceras estomacais em suínos
US5945425A (en) *	1994-04-29	1999-08-31	G.D. Searle & Co.	Method of using (H+ /K+)ATPase inhibitors as antiviral agents
CN1093855C (zh) *	1995-09-21	2002-11-06	帕斯医药股份有限公司	新的含有对酸不稳定的奥美拉唑的组合物及其制备方法
US6645988B2 (en)	1996-01-04	2003-11-11	Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and method of using same
US5840737A (en)	1996-01-04	1998-11-24	The Curators Of The University Of Missouri	Omeprazole solution and method for using same
US6699885B2 (en) *	1996-01-04	2004-03-02	The Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and methods of using same
US6489346B1 (en)	1996-01-04	2002-12-03	The Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and method of using same
KR100463031B1 (ko) *	1997-05-26	2005-04-06	동아제약주식회사	5-메톡시-2-[3,5-디메틸-4-메톡시피리딜메틸)설피닐]-1h-벤즈이미다졸의신규제조방법
US6096340A (en) *	1997-11-14	2000-08-01	Andrx Pharmaceuticals, Inc.	Omeprazole formulation
US6174548B1 (en)	1998-08-28	2001-01-16	Andrx Pharmaceuticals, Inc.	Omeprazole formulation
US6733778B1 (en) *	1999-08-27	2004-05-11	Andrx Pharmaceuticals, Inc.	Omeprazole formulation
US20040006111A1 (en) *	2002-01-25	2004-01-08	Kenneth Widder	Transmucosal delivery of proton pump inhibitors
EP1603537A4 (fr) *	2003-02-20	2009-11-04	Santarus Inc	Liberation immediate d'un complexe antacide d'omeprazole presentant une nouvelle formulation pour une elimination rapide et prolongee d'acide gastrique
US8993599B2 (en) *	2003-07-18	2015-03-31	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
JP2006528181A (ja) *	2003-07-18	2006-12-14	サンタラスインコーポレイティッド	酸分泌を阻害するために有用な薬学的製剤ならびにそれらを作製および使用する方法
JP2006528182A (ja) *	2003-07-18	2006-12-14	サンタラスインコーポレイティッド	薬学的製剤および酸に起因する消化器疾患の治療法
US20070292498A1 (en) *	2003-11-05	2007-12-20	Warren Hall	Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
US8906940B2 (en) *	2004-05-25	2014-12-09	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) *	2004-05-25	2014-08-26	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20060024362A1 (en) *	2004-07-29	2006-02-02	Pawan Seth	Composition comprising a benzimidazole and process for its manufacture
CA2665226C (fr)	2006-10-05	2014-05-13	Santarus, Inc.	Nouvelles formulations pour une liberation immediate d'inhibiteurs de pompe a protons et procedes d'utilisation de ces formulations
US20090092658A1 (en) *	2007-10-05	2009-04-09	Santarus, Inc.	Novel formulations of proton pump inhibitors and methods of using these formulations
AU2007317561A1 (en)	2006-10-27	2008-05-15	The Curators Of The University Of Missouri	Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
WO2024075017A1 (fr)	2022-10-04	2024-04-11	Zabirnyk Arsenii	Inhibition de calcification de valve aortique

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2985661A (en) *	1956-02-06	1961-05-23	American Cyanamid Co	Preparation of 2(omicron-aminophenyl)-benzimidazole
GB1234058A (fr) *	1968-10-21	1971-06-03
SE418966B (sv) *	1974-02-18	1981-07-06	Haessle Ab	Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
SE416649B (sv) *	1974-05-16	1981-01-26	Haessle Ab	Forfarande for framstellning av foreningar som paverkar magsyrasekretionen

1978
- 1978-08-30 IN IN949/CAL/78A patent/IN148930B/en unknown
- 1978-08-31 MC MC781323A patent/MC1213A1/fr unknown
- 1978-09-11 US US05/941,343 patent/US4182766A/en not_active Expired - Lifetime
- 1978-09-12 IL IL55557A patent/IL55557A/xx unknown
- 1978-09-13 NZ NZ188405A patent/NZ188405A/xx unknown
- 1978-09-13 EG EG554/78A patent/EG13530A/xx active
- 1978-09-13 AU AU39817/78A patent/AU519711B2/en not_active Expired
- 1978-09-13 CA CA311,181A patent/CA1106849A/fr not_active Expired
- 1978-09-13 BG BG040865A patent/BG28708A3/xx unknown
- 1978-09-14 FR FR7826420A patent/FR2403340A1/fr active Granted
- 1978-09-14 OA OA56607A patent/OA06054A/fr unknown
- 1978-09-14 DK DK406578A patent/DK406578A/da not_active Application Discontinuation
- 1978-09-14 YU YU02167/78A patent/YU216778A/xx unknown
- 1978-09-14 PH PH21603A patent/PH16342A/en unknown
- 1978-09-15 DD DD78207858A patent/DD138210A5/xx unknown
- 1978-09-18 ES ES473451A patent/ES473451A1/es not_active Expired
- 1978-09-18 SU SU782664651A patent/SU793390A3/ru active
- 1978-09-18 DE DE19782840591 patent/DE2840591A1/de not_active Withdrawn
- 1978-09-18 JP JP11371578A patent/JPS5459274A/ja active Pending
- 1978-09-18 PT PT68573A patent/PT68573A/fr unknown
- 1978-09-18 SE SE7809792A patent/SE7809792L/xx unknown
- 1978-09-18 NO NO783155A patent/NO149962C/no unknown
- 1978-09-18 IE IE1878/78A patent/IE47363B1/en unknown
- 1978-09-18 GB GB7837156A patent/GB2004281B/en not_active Expired
- 1978-09-18 GR GR57249A patent/GR73069B/el unknown
- 1978-09-18 DE DE7878100923T patent/DE2861237D1/de not_active Expired
- 1978-09-18 EP EP78100923A patent/EP0001279B1/fr not_active Expired
- 1978-09-18 FI FI782847A patent/FI64365C/fi not_active IP Right Cessation
- 1978-09-18 HU HU78HO2102A patent/HU176111B/hu unknown
- 1978-09-18 MT MT835A patent/MTP835B/xx unknown
- 1978-09-18 AT AT0673378A patent/AT368152B/de not_active IP Right Cessation
- 1978-09-19 RO RO7895228A patent/RO75258A/fr unknown
- 1978-09-19 AR AR273765A patent/AR224350A1/es active
- 1978-09-19 NL NL7809529A patent/NL7809529A/xx not_active Application Discontinuation
- 1978-09-19 PL PL1978209693A patent/PL114494B1/pl unknown
- 1978-09-19 BR BR7806148A patent/BR7806148A/pt unknown
- 1978-09-19 IT IT27861/78A patent/IT1098858B/it active
1979
- 1979-07-02 US US06/054,210 patent/US4248880A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
FI782847A7 (fi)	1979-03-20
SU793390A3 (ru)	1980-12-30
US4248880A (en)	1981-02-03
US4182766A (en)	1980-01-08
IN148930B (fr)	1981-07-25
IE781878L (en)	1979-03-19
IL55557A (en)	1982-02-28
RO75258A (fr)	1980-11-30
BR7806148A (pt)	1979-04-17
EG13530A (en)	1981-12-31
FI64365C (fi)	1983-11-10
PL114494B1 (en)	1981-01-31
FR2403340A1 (fr)	1979-04-13
JPS5459274A (en)	1979-05-12
DK406578A (da)	1979-03-20
AU519711B2 (en)	1981-12-17
FR2403340B1 (fr)	1981-02-13
IL55557A0 (en)	1978-12-17
IT7827861A0 (it)	1978-09-19
AR224350A1 (es)	1981-11-30
SE7809792L (sv)	1979-03-20
OA06054A (fr)	1981-06-30
PL209693A1 (pl)	1979-06-04
MTP835B (en)	1979-11-14
AU3981778A (en)	1980-03-20
EP0001279A1 (fr)	1979-04-04
NL7809529A (nl)	1979-03-21
GB2004281A (en)	1979-03-28
HU176111B (en)	1980-12-28
ATA673378A (de)	1982-01-15
DE2861237D1 (en)	1981-12-10
CA1106849A (fr)	1981-08-11
BG28708A3 (bg)	1980-06-16
EP0001279B1 (fr)	1981-09-30
NO149962B (no)	1984-04-16
IT1098858B (it)	1985-09-18
DE2840591A1 (de)	1979-03-29
GB2004281B (en)	1982-03-10
GR73069B (fr)	1984-01-30
MC1213A1 (fr)	1979-05-18
NO783155L (no)	1979-03-20
IE47363B1 (en)	1984-03-07
ES473451A1 (es)	1979-05-01
YU216778A (en)	1983-01-21
AT368152B (de)	1982-09-27
NZ188405A (en)	1981-03-16
PH16342A (en)	1983-09-05
FI64365B (fi)	1983-07-29
PT68573A (fr)	1978-10-01
DD138210A5 (de)	1979-10-17

Publication	Publication Date	Title
NO147148C (no)	1983-02-09	Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive fenyletanolaminderivater
NO150800C (no)	1984-12-27	Analogifremgangsmaate ved fremstilling av terapeutisk aktive tricykliske forbindelser
NO151321C (no)	1985-03-20	Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater
NO151463C (no)	1985-04-17	Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolinderivater
NO148148C (no)	1983-08-17	Fremgangsmaate til fremstilling av terapeutisk aktive 4-hydroksy-2-pyrrolidinonderivater
NO800858L (no)	1980-09-29	Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-amino-3-kinolincarboxylsyrederivater
NO156611C (no)	1987-10-21	Analogifremgangsmaate for fremstilling av terapeutiske virksomme derivater av hydroksykarbonylfosfonsyre.
NO151240C (no)	1985-03-06	Analogifremgangsmaate til fremstilling av terapeutisk aktive nitroimidazoler
NO148813C (no)	1983-12-21	Analogifremgangsmaate for fremstilling av farmakologisk aktive karbostyrilderivater
NO800881L (no)	1980-09-29	Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater
NO148777C (no)	1984-01-25	Analogifremgangsmaate for fremstilling av terapeutisk aktive antrakinon-derivater
NO149065C (no)	1984-02-08	Analogifremgangsmaate for fremstilling av terapeutisk aktive benzodiazepinderivater
NO146359C (no)	1982-09-15	Analogifremgangsmaate ved fremstilling av terapeutisk aktive cyproheptadinderivater
NO149313C (no)	1984-03-28	Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO149737C (no)	1984-06-13	Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1-azaxanthon-3-carboxylsyrer
NO149037C (no)	1984-02-01	Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO148454C (no)	1983-10-12	Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-dionderivater
NO148451C (no)	1983-10-12	Analogifremgangsmaate ved fremstilling av terapeutisk aktive oximethere
NO150158C (no)	1984-08-29	Analogifremgangsmaate ved fremstilling av terapeutisk aktive 6,7-dimetoksyquinazolinderivater
NO146057C (no)	1982-07-21	Analogifremgangsmaate ved fremstilling av terapeutisk aktive aminoalkoholderivater
NO149960C (no)	1984-07-25	Analogifremgangsmaate ved fremstilling av terapeutisk aktive bis(nitrosoureido)-polyolderivater
NO794318L (no)	1980-07-23	Analogifremgangsmaate for fremstilling av terapeutisk aktive spiro-kinolyl-hydantoin-derivater
NO780644L (no)	1978-08-25	Fremgangsmaate til fremstilling av terapeutisk virksomme 9-hydroksyetoksymetylguanin-derivater
NO149964C (no)	1984-07-25	Analogifremgangsmaate ved fremstilling av terapeutisk aktive 3-(tetrazol-5-yl)-1-azaxanthoner
NO152556C (no)	1985-10-16	Analogifremgangsmaate for fremstilling av terapeutisk aktive antracen-biskarbonylhydrazoner